Mostrando 2 resultados de: 2
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis
ArticleAbstract: Patients with a first episode of psychosis (FEP) display a broad range of metabolic risk factors relPalabras claves:antipsychotics, DIABÉTES, Metabolic syndrome, metabolism, Psycosis, SchizophreniaAutores:Adrián LLerena, Albacete A., Alonso-Solís A., Amoretti S., Baeza I., Balanzá-Martínez V., Barcones M.F., Bernardo M., Bioque M., Bobes J., Butjosa A., Cabrera B., Cáceres I., Cañete C., Castro-Fornieles J., Contreras F., Corripio I., Cuesta M.J., de la Fuente L., de la Serna E., Díaz J.L., Díaz-Caneja M.C., Eguiluz J.I., Escartí M.J., García-Alvarez L., García-Portilla M.P., García-Rizo C., González-Ortega I., González-Pinto A., Gutiérrez-Fraile M., Ibáñez Á., Landín-Romero R., Lobo A., Martínez-Cengotitabengoa M., Meseguer A., Mezquida G., Morales-Muñoz I., Moreno C., Morilla I., Parellada M., Rabella M., Rodriguez-Jimenez R., Saiz-Ruiz J., Salgado P., Sarró S., Segarra R., Torio I., Torrent C., Usall J., Vieta E.Fuentes:scopusUtility of the MoCA for cognitive impairment screening in long-term psychosis patients
ArticleAbstract: Cognitive impairment is a key feature in patients with psychotic disorders. The Montreal Cognitive APalabras claves:cognitive impairment, Cognitive screening, MoCA, Schizophrenia. psychosisAutores:Ballesteros A., Cuesta M.J., Fañanás L., García de Jalón E., Gil-Berrozpe G.J., Hernández R., Janda L., José Francisco López-Gil, Llano K., López-Ilundain J., Macaya P., Martínez-Parreño E., Moreno-Izco L., Papiol S., Peralta D., Peralta V., Ribeiro M., Rosero Á.S., Saiz H., Sánchez-Torres A.M.Fuentes:scopus